Aquablation Therapy, an innovative and NICE-approved treatment, offers precise and minimally invasive solutions for addressing BPH symptoms. It represents a cutting-edge approach for individuals struggling with an enlarged prostate (BPH). This state-of-the-art procedure utilises robotic technology and the power of water to provide long-lasting relief from BPH symptoms. Aquablation therapy carries an exceptionally low risk of common side effects typically associated with alternative BPH treatments, such as loss of sexual function and incontinence.
Why consider Aquablation therapy?
1. Low Incidence of Irreversible Complications: Clinical studies have consistently demonstrated that Aquablation therapy outperforms traditional surgical options in terms of preserving continence, ejaculation, and erections. Regardless of prostate size and shape, and it delivers consistent and dependable outcomes.
2. Robotic Precision: Aquablation therapy is the only procedure that harnesses robotic technology to guide a heat-free waterjet for precise tissue removal. This advanced technique minimises the risk of human error, guaranteeing accuracy and predictability. By integrating ultrasound imaging and a cystoscope, surgeons gain real-time visualisation of the entire prostate, enhancing surgical precision and lowering the chances of complications.
3. Long-Term Symptom Relief: Patients who undergo Aquablation therapy can anticipate long-lasting relief from BPH symptoms. Clinical studies have indicated significant improvements persisting for up to five years following the procedure.
The recovery process following Aquablation therapy is designed to prioritise patient comfort. Post-procedure, patients may find themselves with a catheter, which facilitates urination during the healing process. Depending on individual progress, some patients may spend the night in the hospital, while others may be discharged on the same day.
One of the notable advantages of Aquablation therapy is that the majority of patients leave the hospital without a catheter. Upon returning home, patients may experience mild burning during urination for several weeks, manageable with mild pain medication. Once granted approval by their doctor, patients can resume their usual activities.